Status:
UNKNOWN
Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease
Lead Sponsor:
Danyang Huichuang Medical Equipment Co., Ltd.
Collaborating Sponsors:
Rehabilitation Hospital Affiliated to National Research Center for Rehabilitation Technical Aids
First Affiliated Hospital of Chongqing Medical University
Conditions:
Mild to Moderate Alzheimer's Disease
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
To explore the efficacy and safety of near infrared light therapy for Alzheimer's disease. Each subject will be numbered and their medical records will be established. The subjects will be randomly as...
Eligibility Criteria
Inclusion
- The age of registration is 50-85 years old, male or female.
- The MMSE score \< 26 points can be used to complete the scale assessment.
- Patients who are not on medication and who are taking psychotropic or cognitive-improving drugs must have a stable dose for at least 12 weeks before the trial and remain the same for the duration of treatment.
- Agree to participate in the clinical trial, willing to maintain the original treatment plan during the trial, and have signed the informed consent
Exclusion
- MRI showed evidence of abnormalities other than Alzheimer's disease, such as cerebral infarction at key sites and severe leukodystrophy (Fezakas\>Level 3).
- There are contraindications to MRI scanning, such as metal implants, claustrophobia, etc.
- A history of stroke or seizures.
- Photosensitive to sunlight or visible light, eczema or increased sensitivity of the skin at the treatment site.
- Severe vision or hearing impairment.
- Alcohol dependence, drug or other drug addiction or addiction tendency.
- During the study , subjects were pregnant, breastfeeding, or planning to pregnancy.
- He/She is currently participating in another study related to the treatment of AD.
- Researchers think that participants could not be included.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06008639
Start Date
March 1 2023
End Date
December 31 2024
Last Update
September 6 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehabilitation hospital affiliated National Research Center for Rehabilitation Technical Aids
Beijing, Beijing Municipality, China, 100000
2
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Sichuan, China, 400000